Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Observational Study Characterizing Patients With Type 1 Diabetes Treated With Teplizumab

NCT06892002 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06892002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06892002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Observational Study Characterizing Patients With Type 1 Diabetes Treated With Teplizumab
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
February 11, 2025
Completion date
August 5, 2025
Enrollment
110 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes